Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2185 - 2192 of 11617 results
Challenging the Legality of a Cruel Immigration Policy
January 31, 2022| Alert| Viewpoint
Massachusetts Takes a Step Closer to Its 2050 Decarbonization Goal: The Commission on Clean Heat Launch
January 31, 2022| Blog| Viewpoint
USCIS Announces H-1B Cap Registration Period for March 2022
January 31, 2022| Alert| Viewpoint
Report on the January 19, 2022 Three Agency “Listening Session” on Provider Non-Discrimination Rules: The Impact on Group Health Plans
January 31, 2022| Blog| Viewpoint
ML Strategies Energy & Sustainability Washington Update — February 2022
January 31, 2022| Blog| Viewpoint
Q&A with Nikki Bell, Founder and CEO of LIFT (Living in Freedom Together)
January 28, 2022| Article| Viewpoint
First Circuit Adopts Deferential Standard for Review of Government Decisions to Dismiss FCA Whistleblower Cases
January 27, 2022| Blog| Viewpoint
Delaware Supreme Court Upholds Advance Waiver of Statutory Appraisal Rights
January 27, 2022| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.